Opinion: Lost lives and long odds: Inside STAT’s decision to take on Purdue
STAT pursued unsealing secret Purdue Pharma documents on OxyContin marketing, even though our lawyers told us the odds of winning were against us and the case would be costly.
by Gideon Gil
Aug 26, 2019
4 minutes
Last month, I got an email from a dear old friend from Kentucky with devastating news. Her daughter Kathryn had died of an opioid overdose. I was stunned, though perhaps I shouldn’t have been. I knew she had long struggled with addiction: A talented artist and writer, she was prescribed an opioid for wrist pain at 19, and that’s all it took. Eventually, she began using heroin, and now she had overdosed on fentanyl. It’s the same tragic path tens of thousands of other young Americans have traveled.
Kathryn’s mother had a request for me. Could I help her find addresses for members of the Sackler family, who founded and still control the opioid maker Purdue
You’re reading a preview, subscribe to read more.
Start your free 30 days